Infectious Diseases | |
|---|---|
| Study Name | Principal Investigator |
| APT.DFI.001 – A phase 2b randomized, parallel group, double-blind, placebo-controlled, repeat dose, multi-site study investigating the safety, tolerability, and efficacy of personalized phage treatment and standard of care antimicrobials for subjects with diabetic foot osteomyelitis due to S. aureus. Read more. |
Suraj Saggar, DO |
| 000422 – REBYOTATM for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study. Read more. |
Suraj Saggar, DO |
